Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors
Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc.
Eisai Inc.
BeiGene
Takeda
4SC AG
Mundipharma Research Limited
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd.
Eisai Inc.
Genmab
Genmab
Atara Biotherapeutics
Karyopharm Therapeutics Inc
Soligenix
Alexion Pharmaceuticals, Inc.
4SC AG
AbbVie
Eisai Inc.
Galderma R&D
Innate Pharma
Takeda
miRagen Therapeutics, Inc.
Eli Lilly and Company
Helsinn Therapeutics (U.S.), Inc
Rhizen Pharmaceuticals SA
Acrotech Biopharma Inc.
Acrotech Biopharma Inc.
Bausch Health Americas, Inc.
Celgene
Celgene
Merck Sharp & Dohme LLC
Angimmune LLC
Janssen Research & Development, LLC
Rhizen Pharmaceuticals SA
Progen Pharmaceuticals
TetraLogic Pharmaceuticals
Morphotek
Valerio Therapeutics
INSYS Therapeutics Inc
Novartis
BioCryst Pharmaceuticals
Seagen Inc.
Pfizer
Eisai Inc.
Eisai Inc.
Eisai Inc.